5-Amino-1MQ Half-Life: How Long It Stays Active

At a glance: 5-Amino-1MQ pharmacokinetic profile

In preclinical animal models, 5-Amino-1MQ exhibits a rapid plasma elimination half-life of 3.5 to 5 hours following systemic administration.

As a selective small-molecule Nicotinamide N-methyltransferase (NNMT) inhibitor, its duration of action depends on tissue enzyme occupancy rather than extended systemic circulation.

Metabolic clearance occurs predominantly through hepatic biotransformation followed by renal excretion of parent compounds and metabolites.

Understanding these clearance dynamics is critical for establishing reproducible dosing frequencies and sampling schedules in preclinical lipid and cellular energy research.

What is 5-Amino-1MQ and how does it function in research?

5-Amino-1MQ (5-amino-1-methylquinolinium) is a membrane-permeable small molecule engineered specifically to inhibit Nicotinamide N-methyltransferase (NNMT). NNMT is a cytosolic enzyme responsible for methylating nicotinamide (NAM) using S-adenosylmethionine (SAM) as a methyl donor. In metabolic tissues such as white adipose tissue and skeletal muscle, elevated NNMT activity depletes intracellular NAD+ precursor pools and restricts energy expenditure.

By selectively blocking NNMT activity, the experimental compound 5 amino 1mq prevents the irreversible consumption of nicotinamide. Preclinical models demonstrate that this inhibition leads to elevated intracellular NAD+ levels, boosted Sirtuin 1 (SIRT1) expression, and enhanced mitochondrial biogenesis. Consequently, researchers study 5-Amino-1MQ for its capacity to improve mitochondrial output, accelerate cellular oxygen consumption, and support fat-metabolism research.

Unlike biological peptides that undergo rapid enzymatic breakdown by peptidases, 5-Amino-1MQ possesses a rigid methylquinolinium scaffold. This structure provides distinct stability characteristics in enzymatic assays, allowing investigators to observe downstream metabolic responses with precision.

What is the preclinical half-life of 5-Amino-1MQ?

In rodent pharmacokinetic studies, the systemic 5-amino-1mq half life is calculated between 3.5 and 5 hours following parenteral administration. Peak plasma concentrations (Cmax) are typically achieved rapidly—often within 30 to 60 minutes (Tmax)—indicating fast systemic absorption and cellular uptake.

The elimination phase follows first-order kinetics. Because the compound clears from systemic circulation within a moderate timeframe, researchers measuring tissue-specific enzymatic inhibition must distinguish between plasma concentration and target-site persistence. Studies evaluating amino 1mq show that despite a 3 to 5-hour plasma half-life, the downstream inhibition of NNMT in adipose tissue can persist longer due to target binding affinity and cellular accumulation.

Primary clearance pathways involve initial oxidation via hepatic cytochrome P450 pathways, followed by renal elimination. Understanding this rate of clearance allows laboratory investigators to model consistent cellular exposure during multi-day animal administration protocols.

What molecular factors drive 5-Amino-1MQ clearance?

The elimination kinetics of 5-Amino-1MQ are dictated by its physical and chemical properties. Weighing approximately 207.27 g/mol, 5-Amino-1MQ is a charged small molecule rather than a complex peptide macromolecule. Key drivers of its clearance rate include:

1. Molecular Weight and Ionization: Its low molecular weight facilitates rapid distribution through vascular and interstitial compartments. However, its permanent positive charge at physiological pH influences membrane transport kinetics and renal tubular excretion.

2. Absence of Acylation or Fatty Acid Conjugation: Unlike lipidated peptide analogs or Drug-Affinity-Complex (DAC) constructs designed for extended serum binding, 5-Amino-1MQ lacks long-chain fatty acids or albumin-binding domains. Without serum albumin recycling mechanisms, it clears substantially faster than acylated biologics.

3. Hepatic Biotransformation Rate: The methylquinolinium ring system undergoes moderate metabolic oxidation in microsomal liver fractions. This steady rate of biotransformation prevents persistent tissue accumulation while maintaining adequate active exposure windows.

4. Interspecies Variations: Pharmacokinetic parameters scale predictably based on metabolic rate. While rodent models exhibit a 3.5 to 5-hour half-life, higher mammalian species with lower basal metabolic rates generally demonstrate reduced clearance rates and longer half-lives.

How does half-life affect in vitro assay design and timing?

When conducting cell culture studies, the medium half-life of 5-Amino-1MQ dictates the timing of compound administration and readout collection. In cell-free or cell-based NNMT inhibition assays, 5-Amino-1MQ maintains structural stability over extended incubation periods because cell culture media lack circulating hepatic clearance enzymes.

However, intracellular enzymatic consumption and passive depletion mean that continuous 24-hour to 48-hour cellular studies often require compound replenishment or specific media-refresh schedules. For optimal reproducibility in vitro:

- Short-term kinetic assays (1–6 hours): Suitable for measuring immediate direct NNMT inhibition, SAM/SAH ratio changes, and initial NAD+ level shifts.

- Medium-term expression assays (12–24 hours): Ideal for observing SIRT1 activation, mitochondrial gene up-regulation, and changes in cellular oxygen consumption rates (OCR).

- Long-term lipid handling assays (48–72 hours): Require media replacement with fresh 5-Amino-1MQ every 12 to 24 hours to prevent concentration decay below the half-maximal inhibitory concentration (IC50).

How does 5-Amino-1MQ compare to related research compounds?

Laboratory investigators evaluating metabolic pathways often compare 5-Amino-1MQ with other small molecules and mitochondrial peptides in our complete research catalog. Pharmacokinetic characteristics differ significantly across these classes:

- 5-Amino-1MQ: Small-molecule NNMT inhibitor. Systemic half-life of ~3.5–5 hours. Targets cellular NAD+ salvage and adipose energy expenditure directly.

- MOTS-c: Mitochondrial-derived peptide. Half-life in serum is brief (~30–60 minutes) due to rapid endopeptidase degradation. Requires specific handling to prevent enzymatic breakdown in plasma samples. View our MOTS-c 10mg product page for reference data.

- AICAR: AMP-activated protein kinase (AMPK) agonist. Half-life is approximately 1.5 to 2 hours in rodents. Clears rapidly via intracellular phosphorylation and purine nucleotide pathway integration. Explore our AICAR research overview for detailed specifications.

- GW501516 (Cardarine): Small-molecule PPAR-delta receptor agonist. Systemic half-life extends up to 24 hours in preclinical models, allowing sustained nuclear receptor engagement from a single daily administration.

Selecting the appropriate agent depends on whether your research model requires brief, high-intensity signaling pulses or sustained receptor/enzyme occupancy.

Criteria for evaluating research compound quality and vendor standards

To ensure reproducible assay outcomes, researchers must partner with suppliers that maintain strict analytical verification standards. When evaluating vendors for small-molecule metabolic inhibitors or peptide reagents, assess the following baseline criteria:

Purity Verification: Every lot must undergo high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to confirm structural identity and a purity threshold of ≥98.0%.

Endotoxin Testing: Endotoxin presence can corrupt cell culture viability and induce artifactual inflammatory responses in animal models. Reagents should yield <0.01 EU/mg via Chromogenic LAL assay.

Sourcing Transparency: Domestic US synthesis and purification prevent environmental degradation and batch variations associated with unverified overseas bulk imports.

Lot Traceability: Every vial should feature batch-specific identifiers directly linked to downloadable analytical documentation.

Fulfillment Infrastructure: Rapid, cold-chain-compatible logistics prevent compound degradation during transit.

Technical Support: Access to analytical chemists and documentation specialists who understand lab-specific research protocols.

Red flags when sourcing 5-Amino-1MQ for laboratory research

The research chemical landscape contains significant variance in material quality. Laboratories should avoid suppliers displaying any of the following commercial red flags:

- Missing or Generic COAs: Vendors supplying generic certificate of analysis templates without batch-specific HPLC chromatograms or raw mass spec data.

- Human Dosing or Clinical Claims: Suppliers promoting research reagents for human consumption, athletic enhancement, or personal therapeutic protocols. True scientific vendors operate exclusively under Laboratory Research Use Only (RUO) guidelines.

- Lack of Endotoxin Quantification: Failing to provide quantitative endotoxin measurement, particularly for compounds used in cellular respiration or live-animal lipid studies.

- Unusually Low Pricing: Material priced far below market baseline often indicates truncated purification steps, residual heavy metals, or synthesis byproducts.

- Ambiguous Chemical Identity: Lack of verified CAS numbers, IUPAC chemical names, or structural formulas on analytical documentation.

Ordering 5-Amino-1MQ from PX1 Research

PX1 Research provides high-purity 5-Amino-1MQ 5mg vials designed specifically for rigorous in vitro and preclinical research applications. Each lot undergoes comprehensive analytical verification to guarantee correct chemical identity, minimal residual solvents, and strict target purity.

When you place an order with PX1 Research, your material is packed in secure, light-shielded, climate-controlled packaging. Orders placed before 3:00 PM EST (Monday–Friday) ship same-day from our fulfillment hubs in California and Arizona via tracked domestic carriers.

Every vial contains a batch code and direct QR link to view HPLC/MS analytical spectra and endotoxin test results. To review current lot availability, batch documentation, or to consult with our technical support team, visit our official research portal.

Ready to advance your laboratory's metabolic research? Order 5 mg vials of 5-Amino-1MQ directly from PX1 Research today.